News

Under the terms of the agreement, Innovent will gain access to EpimAb’s proprietary Fabs-In-Tandem Immunoglobulin (FIT-Ig) platform to develop multiple bispecific antibodies for the Chinese market, including the

Charles River will be a key partner as Moderna continues to grow and advance its pipeline spanning multiple drug modalities and therapeutic areas, conducting nonclinical activities to progress

The acquisition includes Sun Pharma’s oral solid dosage manufacturing facilities in Philadelphia, PA, and Aurora, IL and 15 related pharmaceutical products (the "Acquired Products"). Terms of the transaction

This collaboration involves a $60-million USD investment by MSD at its Brinny manufacturing plant in Innishannon, County Cork, Ireland. MSD in Brinny has been in operation for more

The primary endpoint was a statistically significant change from baseline to week 26 compared to placebo in a patient-reported daily activity scale called Myasthenia Gravis-Activities of Daily Living

Novartis claims that the COMBI-d study of 423 patients is longest Ph III survival follow-up to date of BRAF V600E/K mutation-positive melanoma patients who received a targeted combination

The primary endpoint of the Beacon CRC trial is overall survival (OS), whiles secondary endpoints include progression-free survival (PFS) and objective response rate (ORR). The companies will carry

Baxalta develops, manufactures and commercializes therapies for orphan diseases and underserved conditions in hematology, immunology and oncology. The acquisition is expected to double Shire’s annual revenues to $20bn

Orphan Drug Designation by the FDA provides regulatory and financial incentives to develop therapies for life-threatening or chronically debilitating conditions affecting fewer than 200 000 people in the